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Objectives To estimate, using Bayesian evidence synthesis, the age-
group-specific annual incidence of symptomatic infection with
seasonal influenza in the Netherlands over the period 2005–2007.
Methods The Netherlands population and age group distribution
for 2006 defined the base population. The number of influenza-like
illness (ILI) cases was estimated from sentinel surveillance data and
adjusted for underascertainment using the estimated proportion of
ILI cases that do not consult a general practitioner. The estimated
number of symptomatic influenza (SI) cases was based on indirect
evidence from the surveillance of ILI cases and the proportions of
laboratory-confirmed influenza cases in the 2004/5, 2005/6 and
2006/7 respiratory years. In scenario analysis, the number of SI cases
prevented by increasing vaccination uptake within the 65 + age
group was estimated.
Results The overall symptomatic infection attack rate (SIAR) over
the period 2005–2007 was estimated at 25% (95% credible interval
[CI]: 21–32%); 410 200 SI cases (95% CI: 338 500–518 600) were
estimated to occur annually. Age-group-specific SIARs were
estimated for <5 years at 49% (21–137%), for 5–14 years at 30%
(20–47%), for 15–44 years at 26% (21–32%), for 45–64 years at
19% (14–25%) and for 65 + years at 17% (10–30%). Under
assumed vaccination uptake increases of 5% and 15%, 1970 and
5310 SI cases would be averted.
Conclusions By synthesising the available information on seasonal
influenza and ILI from diverse sources, the annual extent of
symptomatic infection can be derived. These estimates are useful for
assessing the burden of seasonal influenza and for guiding
vaccination policy.
Keywords Bayesian evidence synthesis, incidence, seasonal
influenza, vacciation.
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Introduction
Although infection with the influenza virus is normally self-
limiting within a few weeks and most cases are uncompli-
cated, it is responsible for a relatively high public health and
economic burden.1 Disease burden is primarily due to
complications and excess mortality occurring in the elderly
population, but also due to morbidity amongst all age
groups.2 For the accurate estimation of the annual influenza
disease burden, information on the incidence of symptom-
atic infection is required, which is difficult to observe and
determine because only a subset of cases is normally detected
using national surveillance systems.
The goal of the current study was to estimate the
symptomatic infection attack rate (SIAR) for seasonal influ-
enza in the Netherlands and to derive the unknown annual
total number of persons with symptomatic infection (SI).
The attack rate is an important epidemiological indicator of
the severity of an influenza season; estimation of SIAR
requires data on the number of persons with SI. Although no
direct data exist regarding this quantity, in the Netherlands,
there are a number of indirect sources of data – related to SI –
that may be useful for estimating SI. To make best use of the
available evidence, we employed Bayesian evidence synthesis,
which is an established methodology for integrating all
available relevant sources of evidence – both direct and
indirect – to estimate a given quantity of interest.3,4
This method was applied to combine data on the annual
number of persons reporting influenza-like illness (ILI), rates
at which persons with ILI consult a general practitioner (GP)
and the proportion of true influenza infections amongst
patients with ILI. Determining the incidence of symptomatic
infection, rather than of all infections, was of interest because
of its relevance to the application to disease burden
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estimation; asymptomatic infections are not assumed to
contribute to the burden of seasonal influenza.
Methods
Data sources
Age-specific population data for the Netherlands for 2006
were used to define the base population; data were extracted
from the website of Statistics Netherlands (CBS).5
The annual number of cases with ILI was derived from
consultations for ILI within a sentinel surveillance network
of GPs. These consultation data were provided by the
Continuous Morbidity Registration (CMR) Sentinel General
Practice Network of NIVEL, the Netherlands Institute of
Health Service Research.6 Annual numbers of ILI cases were
stratified by age group and then averaged over the period
2005–2007. We chose a study period prior to the 2009
H1N1 pandemic because the severity and infection attack
rates in 2009 differed from those for seasonal influenza.7
The catchment population sizes of each of the 45 sentinel
GP practices were also supplied. The coverage of this
nationwide sentinel network is approximately 08% of the
population8 (see reference 9 for further details). The CMR
data exclude those persons with ILI who do not consult
a GP.
Virological testing is performed throughout the year on
ILI cases, and test results were aggregated by ‘respiratory
year’ (defined as week 18 of a given year through week 17 of
the following year). Nose and throat swabs are sent weekly by
the sentinel GP practices to the RIVM laboratory for testing
by viral culture and PCR; GPs are requested to swab two ILI
cases per week. The predominant influenza A strain circu-
lating during the 2004/5, 2005/6 and 2006/7 influenza
seasons was H3, although in 2005/2006 influenza B was
more prevalent than A.
An Internet-based monitoring study (‘de Grote Griep-
meting’, or the Great Influenza Survey, GIS) supplied data
on the age-group-specific rates of GP contacts given self-
reported ILI symptoms.10 Data from the GIS study were
first averaged over the respiratory years 2004/5, 2005/6 and
2006/7 and then used to inform the adjustment for
underascertainment of ILI in the Dutch sentinel surveillance
system, to account for the population with ILI that do not
contact a GP, and therefore were not included in the
sentinel GP data.
Evidence synthesis
Multiparameter evidence synthesis is a methodology for
combining multiple sources of evidence to derive estimates
for quantities that cannot easily be measured directly,
typically in a Bayesian framework.3,11 By specifying a model
for the relationships between the various data sources and
the parameters (and related quantities) of interest, estimation
can be carried out by exploiting all the available information
that is directly and indirectly related to the parameters under
consideration.
The Bayesian framework permits prior information (if
available) on these parameters to be combined with observed
data, to produce a posterior distribution, and ensures the
correct propagation of uncertainty on data and parameters to
the final estimates. For those parameters for which no prior
information is available, vague priors are specified. Uncer-
tainty is expressed as credible intervals, which summarise the
posterior distributions of these parameters (e.g. of the size of
the subpopulations and of the probability of detection
(under-reporting) of cases).
Within an evidence synthesis model, we distinguish
between basic and functional parameters: basic parameters
are those model parameters to which a prior distribution is
assigned and functional parameters are defined as the
functions of basic parameters (e.g. the conditional probabil-
ity relating the number of persons with symptomatic
influenza infection to the number of individuals with ILI is
a basic parameter; see Fig. 1). N and ca|b indicate the actual
number of persons in a subpopulation (the number we wish
to estimate) and a generic conditional probability of a given
b, respectively. For example, the subpopulation of individuals
with ILI, NILI, is related to the total population, NPop, by the
conditional probability cILI|Pop, and the number of individ-
uals with SI is related to the subpopulation with ILI by the
conditional probability cSI|ILI.
Figure 1 shows the relationship between the ‘true’ sizes of
the subpopulations of interest (i.e. the actual annual number
of persons with ILI (NILI), and the number of symptomat-
ically infected cases (NSI)), the conditional probabilities
linking the true numbers corresponding to each subpopu-
lation and the sources of direct evidence (data) informing the
model parameters. Dashed arrows indicate functional rela-
tions, and solid arrows indicate distributional (i.e. stochastic)
relationships. In our model (Fig. 1), data on ILI cases from
sentinel surveillance inform the conditional probability cILI|
Pop, and data from virological testing inform the conditional
probability cSI|ILI.
Model specification
Parameters for five separate age groups (<5 years, 5–
14 years, 15–44 years, 45–64 years and 65+ years) were
estimated whenever age-group-specific data or age-group-
specific prior information was available. The task is to
compute the posterior distribution of all parameters,
including the subpopulations (NILI, NSI) (Fig. 1).
Basic parameters
Basic parameters (see Table 1, in the format of reference4)
include parameters relating the numbers in each subpopu-
lation, and conditional and detection probabilities. We
McDonald et al.
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Table 1. Model parameters, the specified prior distribution or functional form, and evidence (direct or indirect, or both) informing the parameter
Parameter
Distribution/functional
form Rationale Evidence
ca,ILI|Pop Beta(1,1) Vague prior, assuming nothing is known
about this parameter
Indirect evidence from observed ILI
cases (GP consultations) from sentinel
surveillance
ca,SI|ILI Beta(1,1) Vague prior, assuming nothing is known
about this parameter
Direct evidence from virological testing
performed on random samples of ILI
cases, age group specific
da,ILI Beta(1,1) Vague prior, assuming nothing is known
about this parameter
Data from the GIS study (Friesma
et al., 2009)10: age-group-specific
numbers of self-reported ILI cases
and ILI cases who visited a GP.
Na,Pop N/A N/A CBS population estimates for 2006
Na,ILI Binomial(Na,Pop,ca,ILIPop) Binomial likelihood of the ‘true’ number of
ILI cases, with parameters population size
and the proportion with ILI
Observed sentinel data on ILI cases;
binomial likelihood for observed data
with detection probability da,ILI.
Na,SI Binomial(Na,ILI,ca,SIILI) Binomial likelihood of the ‘true’ number of
SI cases, with parameters the number of
ILI cases and the proportion with SI
All model assumptions and data
SIARa ca,SI|ILI 9 ca,ILI|Pop Symptomatic infection attack rate is the
product of component conditional
probabilities
All model assumptions and data
Product
NPop
NILI
NSI
Sentinel GP ILI
consultation rates
Virological test data
(sampled ILI patients)
dILI
CSI|ILI
CILI|Pop
SIARFigure 1. Directed acyclic graph of the
relationship between model parameters and
observed data; only one of the five age groups
in the model is shown for clarity. Parameters
include the subpopulations NILI (number with
influenza-like illness) and NSI (number with
symptomatic infection), detection probabilities
(d), conditional probabilities (c) and the
symptomatic infection attack rate (SIAR).
Distributional and functional relationships are
indicated by solid and dashed lines,
respectively. Circles indicate model parameters.
Double circles indicate parameters for which
informative or vague priors are applied.
Incidence of seasonal influenza in the Netherlands
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assume that the actual numbers in the subpopulations NILI
and NSI are binomially distributed.
Na,ILI ~ Binomial(Na,Pop, ca,ILI|Pop)
Na,SI ~ Binomial(Na,ILI, ca,SI|ILI)
ca,ILI|Pop Probability of ILI in the population
ca,SI|ILI Probability of symptomatic influenza infection
given ILI
da,ILI Proportion of true ILI cases that are reported
The prior distributions for these parameters are specified
below.
Functional parameters
The SIAR is the only functional parameter to be estimated
and is expressed as the product of age-group-specific
conditional probabilities.
SIAR ¼ ca;SIjILI  ca;ILIjPop
Size of relevant subpopulations: priors and distributional
assumptions
Influenza-like illness. The probability of ILI occurring in the
population, ca,ILI|Pop (the ILI attack rate), is informed by data
on the annual number of patients with ILI provided by the
sentinel GP surveillance data (a sample of all ILI cases) and
the estimated underascertainment of actual ILI cases. The
number of sampled ILI cases, ya,GP, was assumed to be
binomially distributed, with priors on the detection proba-
bility da,ILI constructed from age-group-specific ascertain-
ment estimated from the Internet-based monitoring (GIS)
study. Ascertainment was defined according to the age-
group-specific number of (self-reported) ILI cases in the GIS
study, na,GIS, and the number of ILI cases from the same
study who reported visiting a GP, ya,GIS. Point estimates of
the proportions of ILI cases reporting having visited a GP
were 0240, 0243, 0196, 0220 and 0309 for the age
groups <5 years, 5–14 years, 15–44 years, 45–64 years and
65+ years, respectively. A vague prior, Beta(1,1), was spec-
ified for the ascertainment parameter da,ILI. Data on the
number of patients with ILI captured by the sentinel GP
network, ya,GP, and the size of the sentinel population, na,GP,
were used directly, together with estimated ascertainment to
account for those ILI cases not consulting a GP, to inform
the conditional probability ca,ILI|Pop.
ya,GIS ~ Binomial(na,GIS, da,ILI)
ya,GP ~ Binomial(na,GP, da,ILI 9 ca,ILI|Pop)
Symptomatic infection. The conditional probability of
being infected with influenza given ILI symptoms is directly
informed by data from annual virological testing of samples
provided by the sentinel GPs, for which the number of
positive cases by age group a and per respiratory year t,
ya,t,VIR, and the denominator (ILI samples tested), na,t,VIR,
were available. This probability also depends on the
sensitivity of the test, p, which was assigned a uniform
prior ranging from 95% to 100%. The test sensitivity was
incorporated into the binomial likelihood for the observed
number of positive samples ya,t,VIR. Positivity rates over the
respiratory years 2004/5, 2005/6 and 2006/7 were on average
259%, 415%, 307%, 263% and 250% for the age groups
<5 years, 5–14 years, 15–44 years, 45–64 years and
65+ years, respectively. A vague prior, Beta(1,1), was
specified for the conditional probability ca,SI|ILI.
p ~ Uniform(095,1)
ya,t,VIR ~ Binomial(na,t,VIR, p 9 ca,SI|ILI)
Scenario analysis
A scenario analysis was conducted to examine the effect of
increasing vaccination uptake amongst the 65 + age group
(estimated at >70% within this age group in the period 1998–
2005 and at >75% in 2008–201012,13) to 80%, 85% and 90%
(assuming uptake was on average 75% in the period 2005–
2007), by quantifying the expected number of SI cases
prevented. The effect of increasing vaccination uptake was
crudely simulated by adjusting the data – specifically, the
number of sentinel-reported ILI cases in the over-65-year-
olds – so that the expected ILI incidence rate (not taking into
account underascertainment) decreased by 17/10 000 per
percentage increase in simulated vaccination uptake. This
parameter estimate (17/10 000) was based on the results of a
linear regression of sentinel-based ILI incidence rates on
vaccine uptake conducted by RIVM.9
Model inference
Sampling from the posterior distributions for each parameter
was carried out via MCMC simulation using OpenBUGS,
version 32114 and the BRugs package for R.15 Two
independent chains were run for 80 000 iterations, with the
first 30 000 iterations ignored (treated as burn-in). Brooks–
Gelman–Rubin diagnostic plots were examined to check that
convergence of the chains was satisfactorily achieved. Pos-
terior estimates were produced for 26 stochastic nodes (5
parameters x 5 age groups, plus test sensitivity p) and for 5
functional nodes (1 parameter x 5 age categories). Figure B1
(Appendix B) shows the overlaid prior and posterior
distributions for an example parameter.
Results
Tables 2 and 3 show the posterior summaries for the various
basic and functional parameters by age group and the
estimated numbers in each level of the population. The
estimated SIAR was highest for the <5 years group (49%,
95% credible interval (CI): 21–137%) and lowest for the
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65+ years group (17%, 95% CI: 10–30%). An annual total
number of 410 200 SI cases (95% CI: 338 500–518 600) was
estimated for the Netherlands. Figure 2 shows the estimated
annual number of ILI and SI cases, stratified by the 5-year
age group.
The effects of the three increased vaccination uptake
scenarios are shown in Table 4. With an increase of 5% in
persons aged 65+ years, a projected 1970 annual cases of SI
would be prevented (50% of the SI cases in the baseline
scenario). With an increase in vaccine uptake of 15%, an
Table 2. Posterior median (95% credible
interval) estimates of SIAR, cILI|Pop and cSI|ILI,
stratified by age group
Age group SIAR (95% CI) cILI|Pop (95% CI) cSI|ILI (95% CI)
<5 years 49% (22–137%) 0180 (0093–0482) 0271 (0168–0395)
5–14 30% (20–47%) 0070 (0050–0103) 0428 (0334–0526)
15–44 26% (21–32%) 0081 (0071–0094) 0316 (0267–0368)
45–64 19% (14–25%) 0070 (0059–0083) 0271 (0215–0335)
65+ 17% (10–30%) 0065 (0046–0102) 0261 (0169–0372)
Total 25% (21–32%) 0082 (0072–0101) 0306 (0265–0350)
SIAR, symptomatic infection attack rate; ILI, influenza-like illness; Pop, population; SI, symptomatic
infection; CI, credible interval.
Figure 2. Posterior median (with 95% credible interval) estimates of the annual number of incident cases of influenza-like illness (NILI) and of
symptomatic infection (NSI), stratified by age group.
Table 3. Posterior median estimates of the
annual numbers of incident cases of ILI and
SI (NILI and NSI, respectively), stratified by
age group
Age group NILI (95% CI) NSI (95% CI)
<5 years 177 400 (90 890–477 500) 48 200 (20 240–137 600)
5–14 139 600 (96 980–209 800) 59 560 (36 230–96 900)
15–44 543 900 (464 400–637 800) 171 800 (132 200–219 300)
45–64 303 300 (249 600–368 900) 82 340 (58 250–112 900)
65+ 151 900 (104 600–239 700) 39 710 (21 350–71 930)
Total 1 336 000 (1 169 000–1 654 000) 410 200 (338 500–518 600)
ILI, influenza-like illness; SI, symptomatic infection; CI, credible interval.
Incidence of seasonal influenza in the Netherlands
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estimated 5310 SI cases would be prevented in this age group
(134% of the baseline SI cases).
Discussion
By synthesising a number of national data sources on ILI and
influenza, we estimated an overall SIAR of 25% for
symptomatic infection with influenza in the Netherlands in
the period 2005–2007. The estimated SIAR varied by age
group and was largest for children under 5 years of age
(49%; NSI of 48 200) and smallest for adults 65 years and
older (17%; NSI of 39 710).
We suggest that the current evidence synthesis model is
of value for projecting the consequences of improved
public health interventions. Influenza vaccination coverage
of the elderly in the Netherlands is amongst the highest in
Europe;16 the results of the vaccination uptake scenario
analysis suggested that even a small increase in vaccination
uptake (of 5%) within the 65 + age group would have a
visible impact on the expected disease burden for influ-
enza, with a predicted 1970 SI cases potentially averted.
Projections are conservative, however, because the potential
for reduced transmission rates expected with increasing
vaccination coverage was not considered. Even without
improvements in vaccination uptake, the burden of
influenza is expected to increase due to demographic
change.17
There are few previous studies that have derived the
incidence of influenza in the Netherlands. The Dutch
Public Health Status and Forecast Studies (DPHSF) used an
estimated influenza incidence of 336 per 10 000 people in
their calculation of disease burden for 2007.18 This
corresponds to an attack rate of 48%, higher than our
estimated overall attack rate. Although the DPHSF estimate
adjusted for the proportion of influenza/ILI cases visiting a
GP (30%), it did not adjust for the proportion of ILI that
were true influenza cases. Another study positions the
attack rate lower, at 1–2% over the period (1997/8 to 2006/
7), but this is based on ILI consultation rates only,19 which
is only one of the data sources synthesised in the current
model.
Bayesian evidence synthesis methods have a number of
advantages, in that diverse sources of information – both in
the form of data and as prior distributions – can be
combined in a coherent framework, and uncertainty around
model parameters is correctly propagated through the model
to the final estimates. In addition, incomplete or missing
information regarding certain parameters, such as for a
subset of age groups/strata considered, can be accommo-
dated by specifying vague prior distributions.
We also explored a version of the model including an
additional subpopulation, those patients hospitalised due to
influenza; results are described in Appendix A. This model
variant was not retained because a lack of age-group-specific
evidence to inform the conditional probability of hospital-
isation given SI entailed an assumption that this probability
was equal across age groups, which conflicted with the age-
specific evidence on NSI, particularly for the youngest age
group. This illustrates that biased estimates of the parameters
of interest can be obtained when the available evidence is
insufficient or in conflict.20
The validity of the estimates derived here, as for any
estimation method, is dependent on the assumptions made
when constructing the model and the quality (representa-
tiveness and bias) of the available data. Children and elderly
persons are under-represented in the Internet-based moni-
toring study, but are the age groups most likely to consult a
GP with ILI; the degree of ascertainment may be underes-
timated for these age groups, leading to overestimation of ILI
and SI incidence. In addition, the number of true ILI cases
may be larger than the number computed from the
proportion of GIS survey participants who reported visiting
their GP (because the likelihood of consulting a GP is
associated with symptom severity, the CMR sentinel surveil-
lance system is less likely to capture the less-severe ILI cases),
and consequently, the incidence of both ILI and SI would be
underestimated. In addition, some self-reported ILI cases
may not be considered ILI by a GP, because the GIS’ defining
symptom set for ILI (sudden fever onset and muscle pain,
and cough and/or sore throat and/or chest pain) is consistent
with other infectious agents.
Other limitations concern representativeness over age
groups in the sentinel surveillance data due to differential
healthcare-seeking behaviour. Working age adults may be
less likely than other age groups to have a GP consultation
(as suggested by the self-reported proportions from the GIS
study) despite having relatively severe ILI, due to time
constraints and/or the knowledge that influenza is self-
limiting. In this instance, the sentinel data may
Table 4. Results of the vaccination uptake scenario analysis: posterior
median (with 95% credible interval) estimates of the annual number
of incident SI cases (NSI) and point estimates of the number of SI cases
averted in persons aged 65 + years (compared with baseline of 0%
increase in uptake)
Simulated increase
in vaccine uptake NSI (95% CI) Averted cases
0% (baseline) 39 710 (21 350–71 930) –
5% 37 740 (20 230–68 690) 1970
10% 36 180 (19 160–65 100) 3530
15% 34 400 (18 210–62 390) 5310
SI, symptomatic infection; CI, credible interval.
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under-represent working age adults, and thus, SIAR and SI
incidence would be correspondingly underestimated. Such
health-seeking behaviour is country specific as well as age
dependent; factors associated with the health care and social
security systems can influence the likelihood of GP consul-
tation. In some countries, GP consultation is required to
legitimate sick leave, but this is not so in the Netherlands.
Such a social security condition may highly influence the
number of GP consultations amongst working persons.
We applied evidence synthesis methods to the period 2005–
2007 and averaged ILI data over these three years, as our goal
was to estimate symptomatic incidence during a typical
influenza season. However, this removes real between-season
variability in incidence; influenza seasons differ with respect
to timing and the number of other respiratory viruses
circulating. We estimated incidence prior to the 2009 H1N1
pandemic because the severity and infection attack rates, and
the age-dependent pattern of attack rates differed substan-
tially from seasonal influenza attack rates in 2009.7
In conclusion, using Bayesian evidence synthesis tech-
niques, we have combined a variety of national data sources
to derive robust estimates for the critical epidemiological
parameters – SIAR and SI incidence – required for the
estimation of the health burden of symptomatic influenza in
the Netherlands. Uncertainty in these estimates, given as 95%
credible intervals, reflects the quantity and quality of the
available data sources.
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Appendix A
In this appendix, we describe the results of additionally
incorporating data on patients hospitalised for influenza and
associated parameters in the evidence synthesis model.
Hospitalised cases within the period 2005–2007 were
extracted from the National Medical Registration (NMR), an
inpatient hospitalisation database maintained by PRIS-
MANT, where an influenza-related hospital episode was
defined as a hospital admission with mention of one or more
of the ICD-9 diagnosis codes 487, 4870, 4871, 4878; counts
were divided into five age groups and averaged over the
period 2005–2007.
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In this model variant, the observed and estimated numbers
of influenza-associated hospitalisations (ya,NMR and NH,
respectively) are incorporated. We added the following basic
parameters and relationships (see Fig. 1A):
ca,H|SI: Probability of hospitalisation given symptomatic
infection
dH: Proportion of all influenza-related hospital admis-
sions that are registered
Na,H ~ Binomial(Na,SI, ca,H|SI): Relationship between influ-
enza-related hospitalisations and symptomatic infections
ya,NMR ~ Binomial(Na,H, dH): Relationship between reg-
istered influenza-related hospital episodes and detection
probability
The number of influenza-related cases in hospital is
assumed to be under-reported, with detection probability dH
constrained to be equal for all age groups. The vague prior
Beta(1,1) was specified for dH, as no information was
available on this parameter. The conditional probability of
being hospitalised given symptomatic infection (ca,H|SI) for
all age groups was assigned the prior Beta(10 7004), which
corresponds to the proportion (014%, 95% CI: 0095–027)
of influenza cases during the 2009 H1N1 pandemic that were
hospitalised in the Netherlands.7
Posterior median estimates of the NILI, NSI and NH
subpopulations are shown in Table 1A. The estimated
median number of incident SI cases within the youngest
age group (<5 years), 107 300, is 22-fold larger than the
estimated SI incidence derived from the evidence synthesis
excluding hospitalisation (48 200). Consequently, both the
overall SIAR (27%) and the SIAR estimated for the youngest
age group (109%) were higher than those estimated from
the model without an H layer.
The reason for the discrepancy in estimated NSI and SIAR
is due to the lack of evidence informing the prior parameters
da,H and the lack of age-group-specific evidence informing
the conditional probability of being hospitalised given
symptomatic infection, ca,H|SI. The latter prior distribution
was specified based on a study of the H1N1 pandemic, the
severity of which may not be comparable with the influenza
strains circulating during the study period. Because the
detection probability dH was not identified by any evidence
sources and the conditional probability cH|SI was a priori
specified as equal across all age groups (although intuitively
cH|SI should be age-dependent; i.e. much lower for children
than for the elderly), many more hospitalised cases for the
<5 years age group were postulated (n = 171) than were
observed (n = 88). This top-down information unduly
influenced the posterior distribution for SI for this age
group, and consequently the SIAR.
Table A1. Posterior median (95% credible interval) estimates of the annual numbers of incident cases of ILI, SI and hospitalisations, stratified by age
group
Age group NILI (95% CI) NSI (95% CI) NH (95% CI)
<5 years 269 800 (175 300–323 600) 107 300 (62 340–149 000) 171 (115–251)
5–14 115 200 (83 730–144 500) 42 250 (32 550–570 30) 43 (27–67)
15–44 525 900 (478 200–589 000) 143 700 (125 200–181 200) 112 (73–167)
45–64 283 800 (246 200–320 800) 74 600 (61 310–94 940) 80 (52–119)
65+ 190 700 (131 500–262 300) 68 460 (43 530–84 950) 137 (93–199)
Total 1 357 000 (1 258 000–1 522 000) 433 500 (397 700–474 000) 547 (369–774)
Figure A1. Directed acyclic graph of the relationship between model
parameters and observed data, additionally including nodes for influenza-
related hospital episode data, the size of the actual hospitalised
subpopulation (NH) and the detection probability (dH).
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Appendix B
In this appendix, we present a supplementary plot to
graphically compare prior and posterior distributions for
an example model parameter (Fig. 1B).
Figure B1. Posterior and prior distributions for the parameter cSI|ILI for the five age groups and the all-ages category. The posterior and prior are,
respectively, indicated with dark blue and light blue lines.
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